Gilead, Galapagos amend commercialisation and development pact for Jyseleca (filgotinib) EP News Bureau Dec 16, 2020 Under the new arrangement, Galapagos will assume sole responsibility in Europe for filgotinib in RA, Gilead to receive royalties…
